A deep passion for improving lives.

Metavention Company Hero Image Mobile Hero Company

One team aligned on one ultimate goal.

Our company is committed to challenging the status quo to deliver better treatment options to the millions of people who need them. Together, with patients and the healthcare professionals who care for them, we can effect real change in the lives of people suffering from metabolic diseases.

Board of Directors

Kevin Hykes

Operating Partner
Revival Healthcare Capital

Matt McAviney, M.D.


Pete McNerney

Independent Director

Timothy Mills, Ph.D.

Managing Director,
Sanderling Ventures

Kirk Nielsen

Managing Partner
Vensana Capital

Ilan Lovinsky, Corporate Counsel

Gunderson Dettmer

Scientific Advisors

Bobak R. Azamian, M.D., Ph.D.

Founder, Metavention, Inc.
CEO of Tarsus Pharmaceuticals, Inc.

Alan D. Cherrington, Ph.D.

Vanderbilt University Professor, Molecular Physiology and Biophysics and Jacquelyn A. Turner and Dorothy J. Turner Chair in Diabetes Research Medicine

Ibrahim A. Hanouneh, M.D.

Director, Department of Gastroenterology and Hepatology, Abbott Northwestern Hospital, Minneapolis, MN Gastroenterologist and Hepatologist, MNGI Digestive Health, Minneapolis, MN Supplemental Consultant, Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN

Prof. Felix Mahfoud, M.D.

Saarland University, Germany
Interventional Cardiologist

Robert A. Rizza, M.D.

Mayo Clinic
Professor of Medicine, Division of Endocrinology, Diabetes, Nutrition and Metabolism

Markus Schlaich, M.D., FAHA, FESC

Dobney Hypertension Centre, School of Medicine and Pharmacology
Royal Perth Hospital Unit, University of Western Australia

Robert J. Smith, M.D.

Brown University
Professor of Medicine (Research), Professor of Health Services, Policy and Practice (Research)